Vessel wall heparan sulfate and transcapillary passage of albumin in experimental diabetes in the rat

Nephrology Dialysis Transplantation

Volumn 12, Issue SUPPL. 2, 1997, Pages 27-31

  Van Den Born, J ^a   Van Kraats, A A ^a   Hill, S ^a   Bakker, M A H ^a   Berden, J H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Albuminuria; Diabetes; Heparan sulfate; Rat; Regional clearance of albumin (TERalb); Transcapillary escape rate of albumin (RCalb)

Indexed keywords

ALBUMIN; HEPARAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; HEART; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES; TISSUE HOMOGENATE;

ANIMALS; BASEMENT MEMBRANE; BLOOD VESSELS; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPARITIN SULFATE; MALE; RATS; RATS, WISTAR; SERUM ALBUMIN;

EID: 0030807037     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kanwar YS, Liu ZZ, Kashihara N, Wallner EI. Current status of the structural and functional basis of glomerular filtration and proteinuria. Semin Nephrol 1991; 11: 390-413
2. Tamsma JT, Born van den J, Bruijn JA et al. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in the glomerular basement membrane. Diabetologia 1994; 37: 313-320
3. Vernier RL, Steffes MW, Sisson-Ross S, Mauer M. Heparan sulfate proteoglycan in the glomerular basement membrane in type I diabetes mellitus. Kidney Int 1992; 41: 1070-1080
4. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219-226
5. Chakrabarti S, Ma N, Sima AAF. Anionic sites in diabetic basement membranes and their possible role in diffusion barrier abnormalities in the BB-rat. Diabetologia 1991; 34: 301-306
6. Tooke JE. Microvascular function in human diabetes. A physiological perspective. Diabetes 1995; 44: 721-726
7. Feldt-Rasmussen B. Increased transcapillary escape rate of albumin in Type I (insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 1986; 29: 282-286
8. Pugliese G, Tilton RG, Speedy A et al. Effects of very mild versus overt diabetes on vascular haemodynamics and barrier function in rats. Diabetologia 1989; 32: 845-857
9. Born van den J, Kraats van AA, Bakker MAH et al. Selective proteinuria in diabetic nephropathy in the rat is associated with a relative decrease in glomerular basement membrane heparan sulfate. Diabetologia 1995; 38: 161-172
10. Born van den J, Kraats van AA, Bakker MAH et al. Reduction of heparan sulphate-associated anionic sites in the glomerular basement membrane of rats with streptozotocin-induced diabetic nephropathy. Diabetologia 1995; 38: 1169-1175
11. Sterling K. Radioactive chromium technique for circulating red cell volume. Methods Med Res 1960; 8: 69-76
12. Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643-651
13. Huijberts MSP, Wolffenbuttel BHR, Crijns FRL, Nieuwenhuijzen Kruseman AC, Bemelmans MHA, Struijker Boudier HAJ. Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats. Diabetologia 1994; 37: 10-14
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275
15. Born van den J, Heuvel van den LPWJ, Bakker MAH, Veerkamp JH, Assmann KJM, Berden JHM. Monoclonal antibodies against the protein core and glycosaminoglycan side chain of glomerular basement membrane heparan sulfate proteoglycan: Characterization and immunohistological application in human tissues. J Histochem Cytochem 1994; 42: 89-102
16. Norgaard K, Jensen T, Feldt-Rasmussen B. Transcapillary escape rate of albumin in hypertensive patients with Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 57-61
17. Bent-Hansen L, Feldt-Rasmussen B, Kverneland A, Deckert T. Plasma disappearance of glycated and non-glycated albumin in type 1 (insulin-dependent) diabetes mellitus: evidence for charge dependent alterations of the plasma to lymph pathway. Diabetologia 1993; 36: 361-363
18. Del van NF, Born van den J, Tamsma JT et al. Effects of glucose on the production of heparan sulfate proteoglycan by mesangial and epithelial cells. Kidney Int 1996; 49: 1079-1089
19. Del van NF, Tamsma JT, Born van den J et al. Differential effects of angiotensin II and transforming growth factor on the production of heparan sulfate proteoglycan by mesangial cells in vitro. J Am Soc Nephrol 1996; 7: 1015-1023
20. Fransson L-A. Structure and function of cell-associated proteoglycans. TIBS 1987; 12: 406-411
21. David G. Integral membrane heparan sulfate proteoglycans. FASEB J 1993; 7: 1023-1030